pyrimidin-2-one beta-ribofuranoside has been researched along with Necrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, KD; Chen, M; Dyer, LM; Hochwald, SN; Hollingshead, M; Hunter, KW; Kaye, FJ; Marquez, VE; Nawab, A; Shabashvili, D; Steeg, P; Yang, SX; Zajac-Kaye, M | 1 |
1 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Necrosis
| Article | Year |
|---|---|
DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer.
Topics: Administration, Oral; Animals; Antigens, Polyomavirus Transforming; Apoptosis; Breast Neoplasms; Cytidine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mice, Transgenic; Necrosis; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Tumor Burden | 2012 |